Comparison
Modafinil vs Methylphenidate
Modafinil
A eugeroic, a wakefulness-promoting compound, originally developed for narcolepsy. The most-studied prescription cognitive enhancer outside of ADHD treatment. Produces 12–15 hour windows of sustained alertness without the euphoria, abuse potential, or cardiovascular load of amphetamines. Prescription-only in nearly every jurisdiction.
Methylphenidate
Prescription stimulant for ADHD (Ritalin, Concerta). Increases dopamine and norepinephrine.
| Field | Modafinil | Methylphenidate |
|---|---|---|
| Category | stimulant | stimulant |
| Dose range | 100–200mg | 5–40mg |
| Half-life | 14h | 3h |
| Onset | 45min | 30min |
| Evidence | EVIDENCEA | EVIDENCEA |
| Safety | ●●●○○ | ●●●○○ |
| Legal (US) | USSchedule IV | USSchedule II |
| PubMed refs | 3200 | 7800 |
The comparison in plain English
Two very different prescription stimulants. Methylphenidate (Ritalin, Concerta) is a direct dopamine and norepinephrine reuptake inhibitor, Schedule II in the US, with significant abuse and dependence potential. Modafinil is a more selective dopamine reuptake inhibitor at Schedule IV with a much lower abuse profile.
Bottom line
For clinically diagnosed ADHD, methylphenidate is the first-line treatment with decades of evidence. For non-ADHD cognitive enhancement or shift-work fatigue, modafinil has the cleaner profile. Methylphenidate's effect window is shorter (3–4 hours IR; longer XR) and the cardiovascular impact is larger.
Choose Modafinil if
You need sustained wakefulness or executive function without the cardiovascular load and abuse potential of methylphenidate. Modafinil is also better tolerated alongside SSRIs for many users.
Choose Methylphenidate if
You have a clinical ADHD diagnosis and your prescriber has chosen methylphenidate. The effect is more pronounced and the rebound shorter than amphetamines.